» Articles » PMID: 10496652

Fundamental Relationships Between the Composition of Pluronic Block Copolymers and Their Hypersensitization Effect in MDR Cancer Cells

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1999 Sep 25
PMID 10496652
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Previous studies have demonstrated that Pluronic block copolymers hypersensitize multiple drug resistant (MDR) cancer cells, drastically increasing the cytotoxic effects of anthracyclines and other anticancer cytotoxics in these cells. This work evaluates the dose dependent effects of these polymers on (i) doxorubicin (Dox) cytotoxicity and (ii) cellular accumulation of P-glycoprotein probe, rhodamine 123 (R123) in MDR cancer cells.

Methods: Dox cytotoxicity and R123 accumulation studies are performed on monolayers of drug-sensitive (KB, MCF-7, Aux-B1) and MDR (KBv, MCF-7/ADR, CHrC5) cells.

Results: Both tests reveal strong effects of Pluronic copolymers observed at concentrations below the critical micelle concentration (CMC) and suggest that these effects are due to the copolymer single chains ("unimers"). Using block copolymers with various lengths of hydrophobic propylene oxide (PO) and hydrophilic ethylene oxide (EO) segments these studies suggest that the potency of Pluronic unimers in MDR cells increases with elevation of the hydrophobicity of their molecule. Optimization of Pluronic composition in R123 accumulation and Dox cytotoxicity studies reveals that Pluronic copolymers with intermediate lengths of PO chains and relatively short EO segments have the highest net efficacy in MDR cells.

Conclusions: The relationship between the structure of Pluronic block copolymers and their biological response modifying effects in MDR cells is useful for determining formulations with maximal efficacy with respect to MDR tumors.

Citing Articles

Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing.

Abraham A, Gyulai G, Mihaly J, Horvath A, Dobay O, Varga Z J Pharm Anal. 2025; 14(12):101020.

PMID: 39881961 PMC: 11774939. DOI: 10.1016/j.jpha.2024.101020.


Application of Pluronics for Enhancing Aqueous Solubility of Lipophilic Microtubule Destabilizing Compounds on the Sea Urchin Embryo Model.

Semenova M, Melik-Nubarov N, Semenov V Int J Mol Sci. 2023; 24(19).

PMID: 37834142 PMC: 10572563. DOI: 10.3390/ijms241914695.


Terminally Phosphorylated Triblock Polyethers Acting Both as Templates and Pore-Forming Agents for Surface Molecular Imprinting of Monoliths Targeting Phosphopeptides.

Huynh C, Diez I, Thi H, Jensen O, Sellergren B, Irgum K ACS Omega. 2023; 8(9):8791-8803.

PMID: 36910939 PMC: 9996590. DOI: 10.1021/acsomega.3c00007.


Strong Variation of Micelle-Unimer Coexistence as a Function of Core Chain Mobility.

Carrazzone R, Li X, Foster J, Uppala V, Wall C, Esker A Macromolecules. 2023; 54(14):6975-6981.

PMID: 36910585 PMC: 10004150. DOI: 10.1021/acs.macromol.1c00635.


Designing fisetin nanocrystals for enhanced anti-angiogenic and anticancer efficacy.

Ma P, Seguin J, Ly N, Henriquez L, Plansart E, Hammad K Int J Pharm X. 2022; 4:100138.

PMID: 36405872 PMC: 9672414. DOI: 10.1016/j.ijpx.2022.100138.


References
1.
van Veen H, Konings W . Multidrug transporters from bacteria to man: similarities in structure and function. Semin Cancer Biol. 1997; 8(3):183-91. DOI: 10.1006/scbi.1997.0064. View

2.
Woodcock D, Linsenmeyer M, Chojnowski G, Kriegler A, Nink V, Webster L . Reversal of multidrug resistance by surfactants. Br J Cancer. 1992; 66(1):62-8. PMC: 1977900. DOI: 10.1038/bjc.1992.217. View

3.
Kabanov A, Chekhonin V, Alakhov VYu , Batrakova E, Lebedev A, Melik-Nubarov N . The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett. 1989; 258(2):343-5. DOI: 10.1016/0014-5793(89)81689-8. View

4.
Lee J, Paull K, Alvarez M, Hose C, Monks A, Grever M . Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol. 1994; 46(4):627-38. View

5.
Scudiero D, Shoemaker R, Paull K, Monks A, Tierney S, Nofziger T . Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988; 48(17):4827-33. View